ZA94748B - Cytotoxic and antiviral compound. - Google Patents

Cytotoxic and antiviral compound.

Info

Publication number
ZA94748B
ZA94748B ZA94748A ZA94748A ZA94748B ZA 94748 B ZA94748 B ZA 94748B ZA 94748 A ZA94748 A ZA 94748A ZA 94748 A ZA94748 A ZA 94748A ZA 94748 B ZA94748 B ZA 94748B
Authority
ZA
South Africa
Prior art keywords
cytotoxic
antiviral compound
compound
kalahide
sacoglossan
Prior art date
Application number
ZA94748A
Other languages
English (en)
Inventor
Paul J Scheuer
Mark T Hamann
Dolores G Gravalos
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of ZA94748B publication Critical patent/ZA94748B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA94748A 1993-02-03 1994-02-03 Cytotoxic and antiviral compound. ZA94748B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939302046A GB9302046D0 (en) 1993-02-03 1993-02-03 Antiumoral compound-v

Publications (1)

Publication Number Publication Date
ZA94748B true ZA94748B (en) 1994-09-29

Family

ID=10729727

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA94748A ZA94748B (en) 1993-02-03 1994-02-03 Cytotoxic and antiviral compound.

Country Status (11)

Country Link
EP (1) EP0610078B1 (da)
JP (1) JP3452628B2 (da)
AT (1) ATE151776T1 (da)
AU (1) AU677258B2 (da)
CA (1) CA2114859C (da)
DE (1) DE69402576T2 (da)
DK (1) DK0610078T3 (da)
ES (1) ES2102772T3 (da)
GB (1) GB9302046D0 (da)
GR (1) GR3024028T3 (da)
ZA (1) ZA94748B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
US7473681B2 (en) 2000-10-31 2009-01-06 Pharma Mar, S.A. Kahalalide F
RU2292216C2 (ru) * 2000-10-31 2007-01-27 Фарма Мар, С.А. Кахалалид f
EP1435990A1 (en) * 2001-10-19 2004-07-14 Pharma Mar, S.A. Kahalalide compounds for use in cancer therapy
GB0304367D0 (en) 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
CN101077885A (zh) * 2002-10-18 2007-11-28 马尔药品公司 新型抗肿瘤化合物
DE60335292D1 (de) * 2002-10-18 2011-01-20 Pharma Mar Sau 4-methylhexanoic kahalalide f verbindung
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
GB0321066D0 (en) 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
CN101861159A (zh) * 2007-10-19 2010-10-13 马尔药品公司 改进的抗肿瘤治疗
AU2009221120A1 (en) * 2008-03-07 2009-09-11 Pharma Mar, S.A. Improved antitumoral treatments
LT3615544T (lt) 2017-04-27 2023-05-10 Pharma Mar S.A. Priešnavikiniai junginiai

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68903907T2 (de) * 1988-09-05 1993-06-09 Sankyo Co Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
US4986988A (en) * 1989-05-18 1991-01-22 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13

Also Published As

Publication number Publication date
GB9302046D0 (en) 1993-03-24
ATE151776T1 (de) 1997-05-15
ES2102772T3 (es) 1997-08-01
GR3024028T3 (en) 1997-10-31
JP3452628B2 (ja) 2003-09-29
AU677258B2 (en) 1997-04-17
CA2114859C (en) 2008-04-15
EP0610078B1 (en) 1997-04-16
AU5491194A (en) 1994-08-11
DE69402576D1 (de) 1997-05-22
DK0610078T3 (da) 1997-10-20
JPH0770185A (ja) 1995-03-14
EP0610078A1 (en) 1994-08-10
DE69402576T2 (de) 1997-10-02
CA2114859A1 (en) 1994-08-04

Similar Documents

Publication Publication Date Title
IL94915A (en) Substituted quinazolinones and pharmaceutical compositions containing them
HU9402342D0 (en) Phosphono-oxymethyl-ethers of taxane derivatives
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
KR0156747B1 (en) Use of 1,3-oxathiolan nucleoside analogues in the treatment of hepatitis-b
TW289020B (da)
TW243415B (da)
AU4755393A (en) Azaquinoxalines, processes for their preparation and their use
HU9302335D0 (en) 9-|(substituted glycyl)-amido¨-6-desmethyl-6-desoxy-tetracyclines
IL106673A (en) 7-(substituted)-9- £(substituted glycyl) amido|-6- demethyl-6- deoxytetracyclines
IL94484A0 (en) Diarylstyrylquinoline diacids and pharmaceutical compositions containing them
CA2075173A1 (en) Compounds and methods for inhibition of hiv and related viruses
AU1485392A (en) Quinoxalines, processes for their preparation, and their use
TW280813B (da)
GR3024028T3 (en) Cytotoxic and antiviral compound.
CA2152771A1 (en) 7-o-ethers of taxane derivatives
ZA955793B (en) Benzothiadiazine compound process for its preparation and the pharmaceutical compositions which contain it
PH31395A (en) Bis-naphthalimides for the treatment of cancer.
MY132057A (en) Quinoxalinones, a process for their preparation and their use
IL109866A0 (en) Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (+) l-hydrogentartrate, its preparation and pharmaceutical compositions containing it
EP0855398A4 (en) SESQUITERPEN DERIVATIVES WITH ANTIVITAL ACTIVITY
EP0551844A3 (da)
CA2014884A1 (en) 5,11-dihydro-6h-pyrido[2,3-b][1,4]benzodiazepin-6-ones and -thiones and their use in the prevention or treatment of aids
AU4706489A (en) Oxadiazol-azabicycl compounds and their pharmaceutical use
ZA931062B (en) Compositions for the treatment of glaucoma.
GR3020597T3 (en) Phospholipids for the treatment of multiple sclerosis